First candidate from Tenvie’s product engine to enter clinical developmentPhase 1 first-in-human study to evaluate single and multiple ascending doses of TNV262 in healthy volunteers and persons with ...
In Alzheimer’s disease, brain damage is often linked to a mix of problems, including beta-amyloid buildup, tau pathology, ...
Boosting the brain's waste-disposal system is increasingly showing promise for Alzheimer's disease, with a study now suggesting that a novel approach eases brain deficits and symptoms associated with ...
The symptom profiles of different neurodegenerative diseases often overlap, and diagnosing age-related cognitive symptoms is ...
Nearly half of all malignant brain tumors in adults are known as glioblastoma multiforme tumors, or GBM’s. They are ...
Illimis Therapeutics, a biotechnology company focusing on central nervous system and immune diseases, closed a $42 million (58 billion KRW) Series B round of financing. Eight existing investors led ...
Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis and high disease perception in the brain are more likely to respond to TNF ...
Most people think of Alzheimer’s disease as an illness of aging. But in fact, the brain changes that characterize it begin ...
Parkinson's disease (PD) is a neurodegenerative disorder that causes tremors, body stiffness and other difficulties with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results